We thank Vrede and colleagues for their interest in the ESGO–ESTRO–ESP guideline update1 and their comments regarding progesterone receptor immunohistochemistry.
[Correspondence] It takes two to tango: importance of oestrogen receptor and progesterone receptor in endometrial cancer – Authors' reply
The Lancet Oncology | | Tjalling Bosse, Remi Nout, Xavier Matias-Guiu, Nicole Concin, ESGO-ESTRO-ESP guidelines authors
Topics: breast-cancer, uterine-cancer